Evidence map›Paper›PMID 38010706›Full record

ArticleThe British journal of dermatology2024

Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease.

Johanna Strobl, Laura M Gail, Laura Krecu, Shaista Madad, Lisa Kleissl, Luisa Unterluggauer, Anna Redl, Kveta Brazdilova, Simona Saluzzo, Philipp Wohlfarth and 5 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The British journal of dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. The ontogeny of synovial tissue macrophages.Frontiers in immunology · 2025
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Johanna StroblDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-3606-2185
Laura M GailDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-2525-9399
Laura KrecuDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5835-6646
Shaista MadadWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0009-0005-4688-8417
Lisa KleisslDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-8011-796X
Luisa UnterluggauerDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-0805-9301
Anna RedlDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4331-6975
Kveta BrazdilovaDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0009-0009-1198-4993
Simona SaluzzoDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2675-4014
Philipp WohlfarthDepartment of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5628-7942
Hanna A KnausDepartment of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9715-5054
Margit MitterbauerDepartment of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5735-2021
Werner RabitschDepartment of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-1138-5287
Muzlifah HaniffaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-3927-2084
Georg StaryDepartment of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-1746-4250
Medical University of Vienna · ATAustrian Academy of Sciences · ATUniversity of Cambridge · GBWellcome Sanger Institute · GB

Funding

Austrian Science Fund FWF P 31494Wellcome TrustWellcome Trust 223092/Z/21/Z
6 · The paper itself

Abstract

backgroundGraft-versus-host disease (GvHD) is a major life-threatening complication of allogeneic haematopoietic stem cell transplantation (HSCT), limiting the broad application of HSCT for haematological malignancies. Cutaneous GvHD is described as a post-transplant inflammatory reaction by skin-infiltrating donor T cells and remaining recipient tissue-resident memory T cells. Despite the major influence of lymphocytes on GvHD pathogenesis, the complex role of mononuclear phagocytes (MNPs) in tissues affected by GvHD is increasingly appreciated.

objectivesTo characterize the identity, origin and functions of MNPs in patients with acute cutaneous GvHD.

methodsUsing single-cell RNA sequencing and multiplex tissue immunofluorescence, we identified an increased abundance of MNPs in skin and blood from 36 patients with acute cutaneous GvHD. In cases of sex-mismatched transplantation, we used expression of X-linked genes to detect rapid tissue adaptation of newly recruited donor MNPs resulting in similar transcriptional states of host- and donor-derived macrophages within GvHD skin lesions.

resultsWe showed that cutaneous GvHD lesions harbour expanded CD163+ tissue-resident macrophage populations with anti-inflammatory and tissue-remodelling properties including interleukin-10 cytokine production. Cell-cell interaction analyses revealed putative signalling to strengthen regulatory T-cell responses. Notably, macrophage polarization in chronic cutaneous GvHD types was proinflammatory and drastically differed from acute GvHD, supporting the notion of distinct cellular players in different clinical GvHD subtypes.

conclusionsOverall, our data reveal a surprisingly dynamic role of MNPs after HSCT. Specific and time-resolved targeting to repolarize this cell subset may present a promising therapeutic strategy in combatting GvHD skin inflammation.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationSkin DiseasesCytokinesHumansMacrophagesCytokines

Identifiers

PMID38010706
PMCPMC10873647
OpenAlexW4389037672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.